Active, Not Recruiting
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
NCT03582475
- Conditions
- Bladder Small Cell Neuroendocrine Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +36 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States